Holocene Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,679
Closed -$525K 892
2025
Q4
$525K Buy
+3,679
New +$493K ﹤0.01% 663
2024
Q3
Sell
-36,943
Closed -$4.39M 793
2024
Q2
$4.39M Buy
36,943
+280
+0.8% +$29.5K 0.02% 357
2024
Q1
$3.93M Buy
36,663
+11,419
+45% +$1.14M 0.01% 453
2023
Q4
$2.52M Buy
25,244
+8,439
+50% +$825K 0.01% 491
2023
Q3
$2M Buy
16,805
+13,059
+349% +$1.95M 0.01% 562
2023
Q2
$668K Sell
3,746
-4,159
-53% -$763K ﹤0.01% 659
2023
Q1
$1.3M Sell
7,905
-13,437
-63% -$2.31M 0.01% 551
2022
Q4
$3.36M Buy
21,342
+9,863
+86% +$1.5M 0.02% 340
2022
Q3
$1.73M Sell
11,479
-6,942
-38% -$1.15M 0.01% 469
2022
Q2
$3.03M Buy
+18,421
New +$3.55M 0.02% 443
2021
Q4
Sell
-16,455
Closed -$3.84M 916
2021
Q3
$3.84M Sell
16,455
-4,939
-23% -$1.04M 0.02% 397
2021
Q2
$4.4M Sell
21,394
-699
-3% -$144K 0.02% 386
2021
Q1
$4.54M Buy
22,093
+9,264
+72% +$1.96M 0.03% 413
2020
Q4
$2.75M Buy
12,829
+5,688
+80% +$1.1M 0.02% 355
2020
Q3
$1.3M Buy
7,141
+5,351
+299% +$1.01M 0.01% 456
2020
Q2
$330K Sell
1,790
-5,458
-75% -$1.08M ﹤0.01% 558
2020
Q1
$1.46M Sell
7,248
-12,038
-62% -$2.32M 0.02% 347
2019
Q4
$3.61M Buy
19,286
+8,800
+84% +$1.51M 0.03% 260
2019
Q3
$1.67M Buy
+10,486
New +$2.09M 0.02% 352
2018
Q4
Sell
-1,635
Closed -$462K 733
2018
Q3
$462K Buy
+1,635
New +$479K 0.01% 563

Other funds holding ICUI

Holocene Advisors's ICUI Position: Q1 2026 in Review

Holocene Advisors sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 3,679 shares — an estimated $525K sold.

Holocene Advisors first reported a position in ICUI in Q3 2018 and held it in 20 quarters. The position peaked at $4.54M in Q1 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Holocene Advisors reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 3,679 ICU Medical shares in Q1 2026, an estimated $525K.
  • Holocene Advisors first reported a position in ICU Medical in Q3 2018 and held it in 20 quarters.
  • Holocene Advisors's ICU Medical position peaked at $4.54M in Q1 2021.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.